The latest report by IMARC Group, titled “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the parenteral nutrition market growth. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global parenteral nutrition market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.
Parenteral nutrition is a medical method of providing nutrients directly into the bloodstream, bypassing the digestive system entirely. This specialized form of feeding is used for individuals who cannot obtain adequate nutrition through oral or enteral routes, due to conditions, such as severe gastrointestinal disorders, certain cancers, bowel obstructions, or after major surgeries that impair the digestive system. It includes a balance of proteins, carbohydrates, fats, vitamins, minerals, and electrolytes, tailored to meet the specific needs of the patient. One of the primary benefits of parenteral nutrition is its ability to deliver essential nutrients when the digestive system is compromised, ensuring patients receive the necessary nourishment for recovery and maintenance of bodily functions. It helps in maintaining muscle mass, preventing malnutrition, and supporting immune function. It allows for precise control over nutrient intake, which is particularly beneficial for patients with complex medical conditions requiring specific dietary adjustments.
Get a Sample Copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample
Market Trends:
At present, rising chronic conditions, such as cancer, diabetes, and gastrointestinal disorders, which often impair the digestive system, represent one of the key factors supporting the growth of the market. These conditions frequently require parenteral nutrition for effective management. Besides this, the growing elderly population is catalyzing the demand for parenteral nutrition, as older adults are more likely to experience health issues that necessitate this type of feeding. In addition, innovations in parenteral nutrition solutions and delivery systems are enhancing the safety, efficacy, and convenience of this treatment, leading to the increased adoption.
Moreover, increasing survival rates of premature infants, who often need specialized nutritional support due to their underdeveloped digestive systems, are propelling the growth of the market. Additionally, the expansion of home healthcare services is driving the demand for parenteral nutrition, as more patients are opting for home-based parenteral nutrition rather than hospital-based treatment. Furthermore, the growing awareness and diagnostic capabilities are leading to better identification of conditions that require parenteral nutrition, thereby expanding the patient population that can benefit from it.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/parenteral-nutrition-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Aculife Healthcare Private Limited
- Braun Melsungen AG
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Otsuka Pharmaceutical Factory Inc.
- Pfizer Inc.
- Servona GmbH
Parenteral Nutrition Market Segmentation:
Our report has categorized the market based on region, nutrient type and end use.
Breakup by Nutrient Type:
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
